American College of Clinical Pharmacy
      Search      Cart
         

IDSAP 2024 Book 2 Infections in Special Populations


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to recieve member pricing. Your ASHP membership number and expiration date are required.

Infectious Diseases Pharmacists are essential in preventing and treating a wide range of infections across diverse patient populations. Infections in Special Populations, the latest release from the Infectious Diseases Self-Assessment Program (IDSAP), provides invaluable resources and practical strategies for effectively preventing and managing infections in pediatric individuals, individuals with central lines, and at-risk youth.

Faculty Panel Chair Jason Child, Pharm.D., BCIDP
Child

The target audience for Infections in Special Populations is board-certified infectious diseases pharmacists who provide care for individuals with or at risk for infectious diseases. Infections in Special Populations contains five learning modules with a total available 23.5 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Jason Child, Pharm.D., BCIDP.

 

The first module offers updates on perinatal and neonatal infections and current treatment options. It also explores the unique challenges of managing HIV in select populations, providing practical considerations for clinicians. The second module explores the intricate interplay between innate and acquired immunodeficiencies and their impact on susceptibility to infections. It explores the risk of infections in patients requiring central venous catheters, offering insights into preventive strategies and management considerations. The third module focuses on outpatient antimicrobial therapy and the complexities of antimicrobial management and stability. Pediatric MSK infections with treatment options are also a focus in the third module. The fourth module focuses on updates to the STI treatment guidelines and alternatives in special populations. It includes the updated diagnosis and treatment guidelines for UTI and asymptomatic bacteria. The final module consists of two case series that provide appropriate diagnosis and treatment for pediatric appendicitis and pneumonia. Overall, this resource offers valuable insights into the diagnosis, treatment, and prevention of infections across diverse patient populations with immune deficiencies.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Case series (major sections of learning content bookended by a sample case and its explained answer)
  • Recorded webcast (PowerPoint presentation; includes PDF of Release Date: November 15, 2024
    BCIDP Deadline: May 15, 2025
    ACPE Deadline: November 15, 2027

    ISBN: 978-1-952291-98-2
    Publication Year: 2024
    Format: PDF and ePub
    Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.